Loading clinical trials...

COMPLETED

Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)

NCT01323075•Centre Hospitalier Universitaire de Nīmes

Summary

The primary objective is to demonstrate a longer period of neurologic recovery from a sensory block assessed in each test group versus the group without metabolic disease.

Eligibility

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•The patient must have given his/her informed and signed consent
•The patient must be insured or beneficiary of a health insurance plan
•The patient is available for 1 month of follow up
•The patient is scheduled for hand or wrist surgery
•Patient has renal insufficiency as defined by a creatine clearance of \< 30ml/min without dialysis
•Patient has chronic hyperglycemia, either a fasting glycemia \> 1.26 g/l (7mmol/l) for longer than 5 years and receiving an oral, well-adjusted (last HBA1c \< 6.5%)), non-insulin, antidiabetic treatment
•Patient without metabolic or neurologic disease, with creating clearance \> 90ml/min

Exclusion Criteria

•The patient is participating in another study
•The patient is in an exclusion period determined by a previous study
•The patient is under judicial protection, under tutorship or curatorship
•The patient refuses to sign the consent
•It is impossible to correctly inform the patient
•The patient is pregnant
•The patient is breastfeeding
•Patient weighs less than 50 kg
•Score ASA \> 4
•contra indication for locoregional anesthesia
+4 more criteria

Locations (3)

Centre Hospitalier Universitaire de Nîmes

Nîmes, Gard, France

Hôpital Lapeyronnie CHU de Montpellier

Montpellier, France

Hôpital Privé Claude Galien

Quincy-sous-Sénart, France

Key Dates

Start Date

May 1, 2011

Primary Completion Date

December 13, 2013

Completion Date

December 13, 2013

Last Updated

November 17, 2025

Enrollment

120

ACTUAL participants

Conditions

Renal InsufficiencyDiabetes

Interventions

Truncal block

PROCEDURE

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

View study

RECRUITINGNA

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 17, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)

Inclusion Criteria

Exclusion Criteria

Genetic Studies of Insulin and Diabetes

Feasibility of a Tailored Online Self-compassion Intervention

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

iGlarLixi CGM Study in Chinese T2D Individuals After OADs

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes